Showing results (351-360 of 401) with videos related to
Sort By:
Pageof 41
Protein Science : a Publication of the Protein Society|January 1, 1997
gamma-Carboxyglutamic acids 36 and 40 do not contribute to human factor IX functionS Gillis, B C Furie, B Furie, et al.Cancer Chemotherapy and Pharmacology|January 27, 1998
Clinical effects and pharmacokinetics of the fusion protein PIXY321 in children receiving myelosuppressive chemotherapyW L Furman, J H Rodman, M E Tonda, et al.Cancer|October 8, 1998
A Phase I study of granulocyte-macrophage-colony stimulating factor/interleukin-3 fusion protein (PIXY321) following ifosfamide, carboplatin, and etoposide therapy for children with recurrent or refractory solid tumors: a report of the Children's Cancer GroupM S Cairo, M D Krailo, J A Weinthal, et al.Leukemia Research|August 24, 1999
Salvage therapy of refractory and relapsed acute leukemia with high dose mitoxantrone and high dose cytarabineP Raanani, O Shpilberg, S Gillis, et al.The EMBO Journal|July 1, 1992
A novel regulatory myosin light chain gene distinguishes pre-B cell subsets and is IL-7 inducibleE M Oltz, G D Yancopoulos, M A Morrow, et al.Proceedings of the National Academy of Sciences of the United States of America|September 1, 1985
Cloning, sequence, and expression of a human granulocyte/macrophage colony-stimulating factorM A Cantrell, D Anderson, D P Cerretti, et al.Nature|June 20, 1985
Cloning, sequence and expression of two distinct human interleukin-1 complementary DNAsC J March, B Mosley, A Larsen, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 1, 1995
Acute promyelocytic leukaemia with t(15;17) following treatment of Hodgkin's disease--a report of 4 casesS Gillis, O Sofer, O Zelig, et al.Cancer Research|February 15, 1990
Enhancement by interleukin 4 of interleukin 2- or antibody-induced proliferation of lymphocytes from interleukin 2-treated cancer patientsJ Treisman, C M Higuchi, J A Thompson, et al.Proceedings of the National Academy of Sciences of the United States of America|January 15, 1993
Development of human mast cells from umbilical cord blood cells by recombinant human and murine c-kit ligandH Mitsui, T Furitsu, A M Dvorak, et al.Pageof 41